eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | lennox-gastaut syndrome |
| Symptom | C0234533|generalized seizures |
| Sentences | 2 |
| PubMedID- 20150505 | Background: rufinamide is an oral antiepileptic drug indicated for adjunctive therapy in treating generalized seizures associated with lennox-gastaut syndrome. |
| PubMedID- 26579319 | Felbamate (fbm, 2-phenyl-1,3-propanediol dicarbamate) was synthesized in 1955 but was first approved in 1993 as a novel antiepileptic to be used as monotherapy and as an adjunctive therapy to treat partial seizures with and without generalization in adults and as an adjunctive therapy for partial and generalized seizures associated with lennox-gastaut syndrome . |
Page: 1